To extend our in vivo findings and further define the molecular mechanisms of Nur77 downregulation in COPD, we tested the effects of CSE treatment on Nur77 in H292 human airway epithelial cells. The gene discussed is NR4A1; the disease is chronic obstructive pulmonary disease.